New monoclonal antibody targets deadly sepsis
Peer-Reviewed Publication
Updates every hour. Last Updated: 10-Sep-2025 16:11 ET (10-Sep-2025 20:11 GMT/UTC)
The antibody also has potential to treat a broad array of other conditions, including autoimmune disorders, cancer and diabetes, research indicates.
With help from artificial intelligence, MIT researchers designed novel antibiotics that can combat a drug-resistant form of Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA).